Enhabit, Inc. (EHAB) Dividend History

Enhabit, Inc. (EHAB) is a home health care provider that offers skilled nursing, therapy, and personal care services. Focused on delivering patient-centered care, the company serves individuals in their homes, aiming to improve quality of life through personalized healthcare solutions.

6688 N. Central Expressway, Suite 1300, Dallas, TX, 75206
Phone: (469) 621-6419
Website:

Dividend History

Enhabit, Inc. currently does not pay dividends

Company News

  • Throughout the last three months, 5 analysts have evaluated Enhabit (NYSE:EHAB), offering a diverse set of opinions from bullish to bearish. The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 1 0 4 0 0 Last 30D 0 0 1 0 0 1M Ago 0 0 1 0 0 2M Ago 0 0 0 0 0 3M Ago 1 0 2 0 0 The 12-month price targets, analyzed by analysts, offer insights with an average target of $10.35, a high estimate of $14.00, and a low estimate of $8.50. This current average represents a 24.29% decrease from the previous average price target of $13.67. Exploring Analyst Ratings: An In-Depth Overview In examining recent analyst actions, we gain insights into how financial experts perceive Enhabit. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets. Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target Whit Mayo Leerink Partners Announces Market Perform $8.50 - Brian Tanquilut Jefferies Lowers Hold $8.75 $14.00 Ryan Langston TD Cowen Lowers Market Perform $11.00 $12.00 A.J. Rice UBS Announces Neutral $9.50 - Brian Tanquilut Jefferies Lowers Buy $14.00 $15.00 Key Insights: Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments ...Full story available on Benzinga.com

    Benzinga
  • Enhabit (EHAB) delivered earnings and revenue surprises of 40% and 2.18%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

    Zacks Investment Research
    Featured Companies: PGNY
  • Surgery Partners (SGRY) delivered earnings and revenue surprises of 42.86% and 1.38%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

    Zacks Investment Research
    Featured Companies: SGRY
  • During the last three months, 3 analysts shared their evaluations of Enhabit (NYSE:EHAB), revealing diverse outlooks from bullish to bearish. The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 1 0 2 0 0 Last 30D 0 0 1 0 0 1M Ago 1 0 1 0 0 2M Ago 0 0 0 0 0 3M Ago 0 0 0 0 0 The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $11.5, a high estimate of $14.00, and a low estimate of $9.50. Experiencing a 14.81% decline, the current average is now lower than the previous average price target of $13.50. Interpreting Analyst Ratings: A Closer Look A comprehensive examination of how financial experts perceive Enhabit is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets. Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target Ryan Langston TD Cowen Lowers Market Perform $11.00 $12.00 A.J. Rice UBS Announces Neutral $9.50 - Brian Tanquilut Jefferies Lowers Buy $14.00 $15.00 Key Insights: Action Taken: Analysts respond to changes in market ...Full story available on Benzinga.com

    Benzinga
  • Shares of HighPeak Energy, Inc. (NASDAQ: HPK) fell sharply during Thursday’s session after the company reported worse-than-expected fourth-quarter revenue results. HighPeak Energy posted GAAP earnings of 66 cents per share, versus market estimates of 65 cents per share. The company’s quarterly sales came in at $301.153 million versus expectations of $339.525 million. HighPeak Energy shares declined 15.3% to $13.49 on Thursday. Here are some other stocks moving in today's mid-day session. Gainers Lytus Technologies Holdings PTV. Ltd. (NASDAQ: LYT) shares jumped 404% to $11.65 after the company announced the launch of Lytus Cloud. CERo Therapeutics Holdings, Inc. (NASDAQ: CERO) gained 167% to $6.81. CERo Therapeutics announced the publication in clinical cancer research a paper titled "Therapeutic Targeting of TIM-4-L With Engineered T CellsFor Acute Myeloid Leukemia." Brera Holdings PLC (NASDAQ: BREA) shares climbed 97.5% to $2.0150 after the company announced that its Executive Chairman, Daniel McClory, acquired a majority stake in the company. Grom Social Enterprises, Inc. (NASDAQ: GROM) gained 88.3% to $1.45. The company announced that it entered into a non-binding letter of intent to acquire Arctic7. Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ) rose 43% to $6.83. Creative Medical Technology announces FDA authorization for groundbreaking Type 1 diabetes prevention therapy under expanded access. Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) gained 40.5% to $8.35 after the company received FDA Breakthrough Therapy Designation for its MM120 program in generalized anxiety disorder. The company also announced 12-week durability data from its Phase 2B study of MM120. ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) jumped 34.2% to $2.1601 after the company announced that its subsidiary BioStrand developed a Foundation AI Model that uses Large Language Models Stacking and HYFT Technology. Beneficient (NASDAQ: BENF) shares rose 28.7% to $0.1287. Beneficient agreed to the financing of liquidity transactions for three separate funds managed by ff Venture Capital. MoneyLion Inc. (NYSE: ML) gained 28.3% to $67.43 ...

    Benzinga
Dividend data last updated 06/07/2025 16:50:53 UTC